201 related articles for article (PubMed ID: 26137206)
1. Potential for specific dihydropyridine calcium channel blockers to have a positive impact on cognitive function in humans: a systematic review.
Peters J; Booth A; Peters R
Ther Adv Chronic Dis; 2015 Jul; 6(4):160-9. PubMed ID: 26137206
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of calcium channel blocker use and cognitive decline/dementia in the elderly.
Peters R; Booth A; Peters J
J Hypertens; 2014 Oct; 32(10):1945-57; discussion 1957-8. PubMed ID: 25068540
[TBL] [Abstract][Full Text] [Related]
3. Calcium channel blockers for people with chronic kidney disease requiring dialysis.
Mugendi GA; Mutua FM; Natale P; Esterhuizen TM; Strippoli GF
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD011064. PubMed ID: 33000470
[TBL] [Abstract][Full Text] [Related]
4. Calcium channel blockers for primary and secondary Raynaud's phenomenon.
Rirash F; Tingey PC; Harding SE; Maxwell LJ; Tanjong Ghogomu E; Wells GA; Tugwell P; Pope J
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD000467. PubMed ID: 29237099
[TBL] [Abstract][Full Text] [Related]
5. Calcium channel blockers for inhibiting preterm labour and birth.
Flenady V; Wojcieszek AM; Papatsonis DN; Stock OM; Murray L; Jardine LA; Carbonne B
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD002255. PubMed ID: 24901312
[TBL] [Abstract][Full Text] [Related]
6. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.
Forette F; Seux ML; Staessen JA; Thijs L; Babarskiene MR; Babeanu S; Bossini A; Fagard R; Gil-Extremera B; Laks T; Kobalava Z; Sarti C; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Birkenhäger WH;
Arch Intern Med; 2002 Oct; 162(18):2046-52. PubMed ID: 12374512
[TBL] [Abstract][Full Text] [Related]
7. Calcium channel blockade and cardiovascular prognosis in the European trial on isolated systolic hypertension.
Staessen JA; Thijs L; Fagard RH; Birkenhäger WH; Arabidze G; Babeanu S; Gil-Extremera B; Bulpitt CJ; Davidson C; de Leeuw PW; Efstratopoulos AD; Fletcher AE; Fogari R; Jääskivi M; Kawecka-Jaszcz K; Nachev C; Petrie JC; Seux ML; Tuomilehto J; Webster J; Yodfat Y
Hypertension; 1998 Sep; 32(3):410-6. PubMed ID: 9740604
[TBL] [Abstract][Full Text] [Related]
8. Dihydropyridine calcium-channel blockers for antihypertensive treatment in older patients--evidence from the Systolic Hypertension in Europe Trial.
Staessen JA; Thijs L; Celis H; Gasowski J; Wang JG; Fagard RH;
S Afr Med J; 2001 Dec; 91(12):1060-8. PubMed ID: 11845604
[TBL] [Abstract][Full Text] [Related]
9. Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
Voyaki SM; Staessen JA; Thijs L; Wang JG; Efstratopoulos AD; Birkenhäger WH; de Leeuw PW; Leonetti G; Nachev C; Rodicio JL; Tuomilehto J; Fagard R;
J Hypertens; 2001 Mar; 19(3):511-9. PubMed ID: 11288822
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Cilnidipine (L/N-type Calcium Channel Blocker) in Treatment of Hypertension: A Meta-Analysis of Randomized and Non-randomized Controlled Trials.
Chakraborty RN; Langade D; More S; Revandkar V; Birla A
Cureus; 2021 Nov; 13(11):e19822. PubMed ID: 34963839
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic drug-drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management.
Zhou YT; Yu LS; Zeng S; Huang YW; Xu HM; Zhou Q
Ther Clin Risk Manag; 2014; 10():17-26. PubMed ID: 24379677
[TBL] [Abstract][Full Text] [Related]
12. How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2).
Thijs L; Staessen JA; Beleva S; Birkenhäger WH; Bulpitt CJ; Celis H; Fletcher AE; Kermova R; Leonetti G; Laks T; Mantov S; Nachev C; Sarti C; Tuomilehto J; Fagard RH;
Curr Control Trials Cardiovasc Med; 2001 Oct; 2(6):298-306. PubMed ID: 11806817
[TBL] [Abstract][Full Text] [Related]
13. Calcium channel blocker use reduces incident dementia risk in elderly hypertensive patients: A meta-analysis of prospective studies.
Hussain S; Singh A; Rahman SO; Habib A; Najmi AK
Neurosci Lett; 2018 Apr; 671():120-127. PubMed ID: 29452176
[TBL] [Abstract][Full Text] [Related]
14. Systolic Hypertension in Europe (Syst-Eur) trial phase 2: objectives, protocol, and initial progress. Systolic Hypertension in Europe Investigators.
Gasowski J; Staessen JA; Celis H; Fagard RH; Thijs L; Birkenhäger WH; Bulpitt CJ; Fletcher AE; Arabidze GG; de Leeuw P; Dollery CT; Duggan J; Kawecka-Jaszcz K; Leonetti G; Nachev C; Safar M; Rodico JL; Rosenfeld J; Seux ML; Tuomilehto J; Webster J; Yodfat Y
J Hum Hypertens; 1999 Feb; 13(2):135-45. PubMed ID: 10100063
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia.
Cunningham EL; Todd SA; Passmore P; Bullock R; McGuinness B
Cochrane Database Syst Rev; 2021 May; 5(5):CD004034. PubMed ID: 34028812
[TBL] [Abstract][Full Text] [Related]
16. Treatment of isolated systolic hypertension in the elderly: the Syst-Eur trial. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
Fagard RH; Staessen JA
Clin Exp Hypertens; 1999; 21(5-6):491-7. PubMed ID: 10423075
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and Effect on Renal Parameters of Amlodipine vs. Other Dihydropyridine Calcium Channel Blockers in Patients with Essential Hypertension: Retrospective Observational Study Based on Real-World Evidence from Electronic Medical Records.
Jadhav U; Mohanan PP; Almeida AF; Abraham G; Khan MY; Gaurav K; Mane A; Vikas S; Jain M; Meel B
Cardiol Ther; 2021 Dec; 10(2):465-480. PubMed ID: 34115326
[TBL] [Abstract][Full Text] [Related]
19. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
[TBL] [Abstract][Full Text] [Related]
20. Calcium channel blockers in cardiovascular pharmacotherapy.
Godfraind T
J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):501-15. PubMed ID: 24872348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
